120 related articles for article (PubMed ID: 36600560)
1. Development of
Kol A; Fan X; Wazynska MA; van Duijnhoven SMJ; Giesen D; Plat A; Van Eenennaam H; Elsinga PH; Nijman HW; de Bruyn M
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600560
[TBL] [Abstract][Full Text] [Related]
2. Development of [
Fan X; Ważyńska MA; Kol A; Perujo Holland N; Fernandes B; van Duijnhoven SMJ; Plat A; van Eenennaam H; Elsinga PH; Nijman HW; de Bruyn M
EJNMMI Res; 2023 Nov; 13(1):100. PubMed ID: 37985555
[TBL] [Abstract][Full Text] [Related]
3. Immuno-PET imaging of tumor endothelial marker 8 (TEM8).
Kuo F; Histed S; Xu B; Bhadrasetty V; Szajek LP; Williams MR; Wong K; Wu H; Lane K; Coble V; Vasalatiy O; Griffiths GL; Paik CH; Elbuluk O; Szot C; Chaudhary A; St Croix B; Choyke P; Jagoda EM
Mol Pharm; 2014 Nov; 11(11):3996-4006. PubMed ID: 24984190
[TBL] [Abstract][Full Text] [Related]
4. A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts.
Paquette M; Phoenix S; Lawson C; Guérin B; Lecomte R; Tai LH; Turcotte ÉE; Leyton JV
EJNMMI Res; 2020 Jun; 10(1):69. PubMed ID: 32592121
[TBL] [Abstract][Full Text] [Related]
5. Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors.
Beckford Vera DR; Smith CC; Bixby LM; Glatt DM; Dunn SS; Saito R; Kim WY; Serody JS; Vincent BG; Parrott MC
PLoS One; 2018; 13(3):e0193832. PubMed ID: 29513764
[TBL] [Abstract][Full Text] [Related]
6. Imaging Very Late Antigen-4 on MOLT4 Leukemia Tumors with Cysteine Site-Specific
Kim M; Jung KH; Kim JL; Koo HJ; Jung HJ; Lee H; Lee KH
Mol Pharm; 2024 Mar; 21(3):1353-1363. PubMed ID: 38282332
[TBL] [Abstract][Full Text] [Related]
7. Converting an Anti-Mouse CD4 Monoclonal Antibody into an scFv Positron Emission Tomography Imaging Agent for Longitudinal Monitoring of CD4
Islam A; Pishesha N; Harmand TJ; Heston H; Woodham AW; Cheloha RW; Bousbaine D; Rashidian M; Ploegh HL
J Immunol; 2021 Sep; 207(5):1468-1477. PubMed ID: 34408009
[TBL] [Abstract][Full Text] [Related]
8. [
Gallegos CA; Lu Y; Clements JC; Song PN; Lynch SE; Mascioni A; Jia F; Hartman YE; Massicano AVF; Houson HA; Lapi SE; Warram JM; Markert JM; Sorace AG
Theranostics; 2024; 14(3):911-923. PubMed ID: 38250045
[No Abstract] [Full Text] [Related]
9. Imaging of cell-based therapy using
Kurebayashi Y; Choyke PL; Sato N
Nanotheranostics; 2021; 5(1):27-35. PubMed ID: 33391973
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography imaging with
Kasten BB; Houson HA; Coleman JM; Leavenworth JW; Markert JM; Wu AM; Salazar F; Tavaré R; Massicano AVF; Gillespie GY; Lapi SE; Warram JM; Sorace AG
Sci Rep; 2021 Jul; 11(1):15384. PubMed ID: 34321569
[TBL] [Abstract][Full Text] [Related]
11.
Miedema IHC; Wijngaarden JE; Pouw JEE; Zwezerijnen GJC; Sebus HJ; Smit E; de Langen AJ; Bahce I; Thiele A; Vugts DJ; Boellaard R; Huisman MC; Menke-van der Houven van Oordt CW
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067257
[TBL] [Abstract][Full Text] [Related]
12. In Vivo PET Tracking of
Man F; Lim L; Volpe A; Gabizon A; Shmeeda H; Draper B; Parente-Pereira AC; Maher J; Blower PJ; Fruhwirth GO; T M de Rosales R
Mol Ther; 2019 Jan; 27(1):219-229. PubMed ID: 30429045
[TBL] [Abstract][Full Text] [Related]
13. Effective rational humanization of a PASylated anti-galectin-3 Fab for the sensitive PET imaging of thyroid cancer in vivo.
Peplau E; De Rose F; Eichinger A; Reder S; Mittelhäuser M; Scafetta G; Schwaiger M; Weber WA; Bartolazzi A; D'Alessandria C; Skerra A
Sci Rep; 2021 Apr; 11(1):7358. PubMed ID: 33795750
[TBL] [Abstract][Full Text] [Related]
14. PET Imaging of Small Extracellular Vesicles
Khan AA; Man F; Faruqu FN; Kim J; Al-Salemee F; Carrascal-Miniño A; Volpe A; Liam-Or R; Simpson P; Fruhwirth GO; Al-Jamal KT; T M de Rosales R
Bioconjug Chem; 2022 Mar; 33(3):473-485. PubMed ID: 35224973
[TBL] [Abstract][Full Text] [Related]
15. ImmunoPET imaging of TIGIT in the glioma microenvironment.
Vincze SR; Jaswal AP; Frederico SC; Nisnboym M; Li B; Xiong Z; Sever RE; Sneiderman CT; Rodgers M; Day KE; Latoche JD; Foley LM; Hitchens TK; Frederick R; Patel RB; Hadjipanayis CG; Raphael I; Nedrow JR; Edwards WB; Kohanbash G
Sci Rep; 2024 Mar; 14(1):5305. PubMed ID: 38438420
[TBL] [Abstract][Full Text] [Related]
16. Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with
Patrick PS; Kolluri KK; Zaw Thin M; Edwards A; Sage EK; Sanderson T; Weil BD; Dickson JC; Lythgoe MF; Lowdell M; Janes SM; Kalber TL
Stem Cell Res Ther; 2020 Jun; 11(1):256. PubMed ID: 32586403
[TBL] [Abstract][Full Text] [Related]
17. Tracking the fate of bacteria-derived site-specific immunomodulators by positron emission tomography.
Kirby A; Suchý M; Duan D; Bazett M; Kalyan S; Shuhendler AJ
Nucl Med Biol; 2024; 132-133():108908. PubMed ID: 38599145
[TBL] [Abstract][Full Text] [Related]
18. Positron Emission Tomography Imaging of Cell Trafficking: A Method of Cell Radiolabeling.
Bansal A; DeGrado TR; Pandey MK
J Vis Exp; 2023 Oct; (200):. PubMed ID: 37955388
[TBL] [Abstract][Full Text] [Related]
19. Non-specific irreversible
Wijngaarden JE; Jauw YWS; Zwezerijnen GJC; de Wit-van der Veen BJ; Vugts DJ; Zijlstra JM; van Dongen GAMS; Boellaard R; Menke-van der Houven van Oordt CW; Huisman MC
EJNMMI Res; 2024 Feb; 14(1):18. PubMed ID: 38358425
[TBL] [Abstract][Full Text] [Related]
20. First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody.
Omidvari N; Jones T; Price PM; Ferre AL; Lu J; Abdelhafez YG; Sen F; Cohen SH; Schmiedehausen K; Badawi RD; Shacklett BL; Wilson I; Cherry SR
Sci Adv; 2023 Oct; 9(41):eadh7968. PubMed ID: 37824612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
